These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34638864)

  • 1. Tomato Bushy Stunt Virus Nanoparticles as a Platform for Drug Delivery to Shh-Dependent Medulloblastoma.
    Lico C; Tanno B; Marchetti L; Novelli F; Giardullo P; Arcangeli C; Pazzaglia S; Podda MS; Santi L; Bernini R; Baschieri S; Mancuso M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-Functionalized and Drug-Loaded Tomato Bushy Stunt Virus Nanoparticles Counteract Tumor Growth in a Mouse Model of Shh-Dependent Medulloblastoma.
    Marchetti L; Novelli F; Tanno B; Leonardi S; Hizam VM; Arcangeli C; Santi L; Baschieri S; Lico C; Mancuso M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of Tomato Bushy Stunt Virus with a Genetically Fused C-End Rule Peptide.
    Marchetti L; Simon-Gracia L; Lico C; Mancuso M; Baschieri S; Santi L; Teesalu T
    Nanomaterials (Basel); 2023 Apr; 13(8):. PubMed ID: 37111013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
    Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a DCL2-Insensitive
    Incarbone M; Scheer H; Hily JM; Kuhn L; Erhardt M; Dunoyer P; Altenbach D; Ritzenthaler C
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33023227
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of Tomato bushy stunt virus-based vectors for fusion and non-fusion expression of heterologous proteins in an alternative host Nicotiana excelsiana.
    Zhang X; Ding X; Li Z; Wang S
    Appl Microbiol Biotechnol; 2020 Oct; 104(19):8413-8425. PubMed ID: 32830290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.
    Kim J; Dey A; Malhotra A; Liu J; Ahn SI; Sei YJ; Kenney AM; MacDonald TJ; Kim Y
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24205-24212. PubMed ID: 32934143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium ions modulate the mechanics of tomato bushy stunt virus.
    Llauró A; Coppari E; Imperatori F; Bizzarri AR; Castón JR; Santi L; Cannistraro S; de Pablo PJ
    Biophys J; 2015 Jul; 109(2):390-7. PubMed ID: 26200875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
    Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
    Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenovin-6 exhibits inhibitory effects on the growth of Sonic Hedgehog (SHH) medulloblastoma, as evidenced by both in vitro and in vivo studies.
    Wang B; Xu T; Qiu C; Yu L; Xu S; Zhao X; Xu C; Tan F; Sheng H; Zhang N
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113075. PubMed ID: 39260312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma.
    Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q
    Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
    Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U
    Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
    Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
    Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression.
    Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V
    Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma.
    Bell JB; Rink JS; Eckerdt F; Clymer J; Goldman S; Thaxton CS; Platanias LC
    Sci Rep; 2018 Jan; 8(1):1211. PubMed ID: 29352211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restore the brake on tumor progression.
    Gordon RE; Zhang L; Yang ZJ
    Biochem Pharmacol; 2017 Aug; 138():1-6. PubMed ID: 28389227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.
    Doucette TA; Yang Y; Pedone C; Kim JY; Dubuc A; Northcott PD; Taylor MD; Fults DW; Rao G
    Neurosurgery; 2012 Apr; 70(4):1003-10; discussion 1010. PubMed ID: 22037313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.